
Anna Kathy Aman
Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3249 |
| Pending Applications | 17 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13672613
[patent_doc_number] => 20160375040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => TOPICAL COMPOSITION WITH VITAMIN D3
[patent_app_type] => utility
[patent_app_number] => 15/125141
[patent_app_country] => US
[patent_app_date] => 2014-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2560
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15125141
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/125141 | Topical composition with vitamin D3 | Mar 9, 2014 | Issued |
Array
(
[id] => 9739480
[patent_doc_number] => 20140275200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'INHIBITION OF NEOVASCULARIZATION BY SIMULTANEOUS INHIBITION OF PROSTANOID IP AND EP4 RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 14/197948
[patent_app_country] => US
[patent_app_date] => 2014-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6493
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14197948
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/197948 | Inhibition of neovascularization by simultaneous inhibition of prostanoid IP and EP4 receptors | Mar 4, 2014 | Issued |
Array
(
[id] => 9806448
[patent_doc_number] => 20150018393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'TREATMENT OF CANCERS WITH ACQUIRED RESISTANCE TO KIT INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/197940
[patent_app_country] => US
[patent_app_date] => 2014-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9177
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14197940
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/197940 | TREATMENT OF CANCERS WITH ACQUIRED RESISTANCE TO KIT INHIBITORS | Mar 4, 2014 | Abandoned |
Array
(
[id] => 10613785
[patent_doc_number] => 09333212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Proteasome inhibitors as ovoprotective agents to shield the ovary from chemotherapy toxicity'
[patent_app_type] => utility
[patent_app_number] => 14/190550
[patent_app_country] => US
[patent_app_date] => 2014-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13840
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14190550
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/190550 | Proteasome inhibitors as ovoprotective agents to shield the ovary from chemotherapy toxicity | Feb 25, 2014 | Issued |
Array
(
[id] => 9813190
[patent_doc_number] => 20150025135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'Methods and Compositions for Treating Leukemia'
[patent_app_type] => utility
[patent_app_number] => 14/184982
[patent_app_country] => US
[patent_app_date] => 2014-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16063
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14184982
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/184982 | Methods and compositions for treating leukemia | Feb 19, 2014 | Issued |
Array
(
[id] => 11640959
[patent_doc_number] => 09662307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/184425
[patent_app_country] => US
[patent_app_date] => 2014-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28268
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14184425
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/184425 | Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof | Feb 18, 2014 | Issued |
Array
(
[id] => 11640959
[patent_doc_number] => 09662307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/184425
[patent_app_country] => US
[patent_app_date] => 2014-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28268
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14184425
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/184425 | Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof | Feb 18, 2014 | Issued |
Array
(
[id] => 9838506
[patent_doc_number] => 20150030587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'HUMAN PAPILLOMA VIRUS AS PREDICTOR OF CANCER PROGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 14/177615
[patent_app_country] => US
[patent_app_date] => 2014-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 32158
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14177615
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/177615 | Human papilloma virus as predictor of cancer prognosis | Feb 10, 2014 | Issued |
Array
(
[id] => 10588757
[patent_doc_number] => 09310364
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-04-12
[patent_title] => 'High-affinity small molecule formylpeptide receptor ligands from screening of combinatorial mixture-based libraries'
[patent_app_type] => utility
[patent_app_number] => 14/174564
[patent_app_country] => US
[patent_app_date] => 2014-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 32
[patent_no_of_words] => 29217
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14174564
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/174564 | High-affinity small molecule formylpeptide receptor ligands from screening of combinatorial mixture-based libraries | Feb 5, 2014 | Issued |
Array
(
[id] => 12036029
[patent_doc_number] => 09814235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Method for controlling arthropod pest'
[patent_app_type] => utility
[patent_app_number] => 14/655967
[patent_app_country] => US
[patent_app_date] => 2014-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 188361
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655967
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/655967 | Method for controlling arthropod pest | Jan 23, 2014 | Issued |
Array
(
[id] => 16769721
[patent_doc_number] => 10980804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Methods of treating cholangiocarcinoma
[patent_app_type] => utility
[patent_app_number] => 14/761518
[patent_app_country] => US
[patent_app_date] => 2014-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 45666
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14761518
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/761518 | Methods of treating cholangiocarcinoma | Jan 16, 2014 | Issued |
Array
(
[id] => 9462700
[patent_doc_number] => 20140127127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'HEPSIN INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/157347
[patent_app_country] => US
[patent_app_date] => 2014-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25170
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14157347
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/157347 | Hepsin inhibitors | Jan 15, 2014 | Issued |
Array
(
[id] => 16876818
[patent_doc_number] => 11026938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Therapeutical composition containing apomorphine as active ingredient
[patent_app_type] => utility
[patent_app_number] => 14/152000
[patent_app_country] => US
[patent_app_date] => 2014-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4655
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14152000
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/152000 | Therapeutical composition containing apomorphine as active ingredient | Jan 9, 2014 | Issued |
Array
(
[id] => 10182727
[patent_doc_number] => 09212399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-15
[patent_title] => 'Biological specimen collection and transport system and method of use'
[patent_app_type] => utility
[patent_app_number] => 14/149278
[patent_app_country] => US
[patent_app_date] => 2014-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 24
[patent_no_of_words] => 16135
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14149278
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/149278 | Biological specimen collection and transport system and method of use | Jan 6, 2014 | Issued |
Array
(
[id] => 10634511
[patent_doc_number] => 09351998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-31
[patent_title] => 'Methods of nourishing animals'
[patent_app_type] => utility
[patent_app_number] => 14/148242
[patent_app_country] => US
[patent_app_date] => 2014-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 83
[patent_no_of_words] => 23928
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14148242
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/148242 | Methods of nourishing animals | Jan 5, 2014 | Issued |
Array
(
[id] => 11843352
[patent_doc_number] => 09730890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Bronchodilating beta-agonist compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 14/142438
[patent_app_country] => US
[patent_app_date] => 2013-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10248
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14142438
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/142438 | Bronchodilating beta-agonist compositions and methods | Dec 26, 2013 | Issued |
Array
(
[id] => 11581233
[patent_doc_number] => 09635852
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Pymetrozine suspension concentrates and its preparation method'
[patent_app_type] => utility
[patent_app_number] => 15/107027
[patent_app_country] => US
[patent_app_date] => 2013-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10234
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15107027
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/107027 | Pymetrozine suspension concentrates and its preparation method | Dec 22, 2013 | Issued |
Array
(
[id] => 9450016
[patent_doc_number] => 20140121186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'Compounds, Compositions and Methods for Treating Ocular Conditions'
[patent_app_type] => utility
[patent_app_number] => 14/139294
[patent_app_country] => US
[patent_app_date] => 2013-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11875
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14139294
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/139294 | Compounds, Compositions and Methods for Treating Ocular Conditions | Dec 22, 2013 | Abandoned |
Array
(
[id] => 10387936
[patent_doc_number] => 20150272943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'SOLID DISPERSION WITH IMPROVED SOLUBILITY COMPRISING TETRAZOLE DERIVATIVE AS AN ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 14/439735
[patent_app_country] => US
[patent_app_date] => 2013-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4165
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439735
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/439735 | Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredient | Dec 11, 2013 | Issued |
Array
(
[id] => 10421088
[patent_doc_number] => 20150306099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 14/647462
[patent_app_country] => US
[patent_app_date] => 2013-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19361
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14647462
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/647462 | COMBINATION | Nov 25, 2013 | Abandoned |